Our finding suggests that the RAGE gene and its protein are potential targets to limit abnormal amyloid accumulation and tau protein modification, which may have an impact in terms of inhibiting the progression of Alzheimer’s disease-type neurodegeneration after ischemia. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.